(19)
(11) EP 4 562 160 A1

(12)

(43) Date of publication:
04.06.2025 Bulletin 2025/23

(21) Application number: 23846612.2

(22) Date of filing: 27.07.2023
(51) International Patent Classification (IPC): 
C12N 15/13(2006.01)
C07K 16/28(2006.01)
C07K 16/18(2006.01)
C07K 16/46(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/18; C07K 16/2809; C07K 16/2851; C07K 16/2878; C07K 2317/31; C07K 2317/75; C07K 16/2803; C07K 2319/33; C07K 14/7056
(86) International application number:
PCT/JP2023/027536
(87) International publication number:
WO 2024/024882 (01.02.2024 Gazette 2024/05)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 28.07.2022 EP 22187636

(71) Applicant: CHUGAI SEIYAKU KABUSHIKI KAISHA
Tokyo 115-8543 (JP)

(72) Inventors:
  • ER, Jun Zhi
    Synapse, 138623 (SG)
  • IGAWA, Tomoyuki
    Tokyo 103-8324 (JP)

(74) Representative: Simmons & Simmons LLP (Munich) 
Lehel Carré Gewürzmühlstraße 11
80538 Munich
80538 Munich (DE)

   


(54) MOLECULE SPECIFICALLY ACTING IN A TISSUE WHERE A CELL DEATH BEING OBSERVED